Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioMimetic Amends Augment Bone Graft PMA, Expects Approval By 2014

This article was originally published in The Gray Sheet

Executive Summary

BioMimetic Therapeutics submits PMA amendment for its Augment bone graft device to address questions raised by FDA in a “not approvable” letter disclosed in January.

Advertisement

Related Content

News Briefs: FDA Turns Down Wright’s Augment; Cook Resumes Zilver PTX Shipments; Luminex Restructures
Wright Medical Augments Ortho Extremities Biz With BioMimetic Purchase
Deals Of The Week: Algeta/Ablynx, Pfizer/Cystic Fibrosis Foundation, Paladin/Ativa
FDA Wants More Analysis From BioMimetic On Augment Bone Graft
FDA Panel Narrowly Supports BioMimetic's Augment Synthetic Bone Graft

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT031381

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel